Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Common Name
Zhangzhou Pientzehuang Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
2,839
Ticker
600436
Exchange
SHANGHAI STOCK EXCHANGE
Description
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, renowned for producing traditional Chinese medicines. The company's flagship product, Pientzehuang...

Zhangzhou Pientzehuang Pharmaceutical's GHG Emissions Data Preview

In 2023, Zhangzhou Pientzehuang Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Zhangzhou Pientzehuang Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Zhangzhou Pientzehuang Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zhangzhou Pientzehuang Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Zhangzhou Pientzehuang Pharmaceutical's ESG Report 2023
a. Zhangzhou Pientzehuang Pharmaceutical's ESG Report 2023

Insights into Zhangzhou Pientzehuang Pharmaceutical's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Zhangzhou Pientzehuang Pharmaceutical amounted to 9,734.23 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Zhangzhou Pientzehuang Pharmaceutical's Scope 1 Emissions Over Time

202306001.2 k1.8 k2.4 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Zhangzhou Pientzehuang Pharmaceutical's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Zhangzhou Pientzehuang Pharmaceutical were 2,300.93 metric tons of CO₂ equivalent (tCO₂e). a

What are Zhangzhou Pientzehuang Pharmaceutical's Scope 2 emissions?

In 2023, Zhangzhou Pientzehuang Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 7,433.3 tCO₂e without specifying the calculation method. a

What methodology does Zhangzhou Pientzehuang Pharmaceutical use for Scope 2 reporting?

In 2023, Zhangzhou Pientzehuang Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a

Zhangzhou Pientzehuang Pharmaceutical's Scope 2 Emissions Over Time

202302 k4 k6 k8 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Zhangzhou Pientzehuang Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Zhangzhou Pientzehuang Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 2,300.93 tCO₂e and total revenues of USD 1,415 millions. This translates into an emissions intensity of 1.63 tCO₂e per millions USD. a

Zhangzhou Pientzehuang Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers

1020010,000200,00010,000,000Scope 1 Emissions (tCO2e)502002,00010,00050,000Revenues (Millions of USD)CHPYBCJCTZInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MSnibeYear: 2023Scope 1: 210 tCO2eRevenue: $M 553Scope 1 Intensity: 0.38 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MHangzhou Tigermed ConsultingYear: 2024Scope 1: 210 tCO2eRevenue: $M 905Scope 1 Intensity: 0.23 tCO2e/$MCCCR MedicalYear: 2023Scope 1: 1,359 tCO2eRevenue: $M 1,556Scope 1 Intensity: 0.87 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 7,404Scope 1 Intensity: 0.43 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MHHHygeia Healthcare HoldingsYear: 2023Scope 1: 2,681 tCO2eRevenue: $M 627Scope 1 Intensity: 4.27 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYYYifeng Pharmacy ChainYear: 2024Scope 1: 1,082 tCO2eRevenue: $M 3,297Scope 1 Intensity: 0.33 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MUnited ImagingYear: 2023Scope 1: 26,821 tCO2eRevenue: $M 1,606Scope 1 Intensity: 16.71 tCO2e/$MBBBaiyunshan Pharmaceutical HoldingsYear: 2024Scope 1: 34,043 tCO2eRevenue: $M 10,276Scope 1 Intensity: 3.31 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MCCCSPC Pharmaceutical GroupYear: 2024Scope 1: 474,567 tCO2eRevenue: $M 4,327Scope 1 Intensity: 109.67 tCO2e/$MJJJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$MCCChina Evergrande New Energy Vehicle GroupYear: 2023Scope 1: 1,029 tCO2eRevenue: $M 206Scope 1 Intensity: 4.99 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$M

How does Zhangzhou Pientzehuang Pharmaceutical's GHG emissions intensity compare to its peers?

In 2023, Zhangzhou Pientzehuang Pharmaceutical reported a Scope 1 emissions intensity of 1.63 tCO₂e per millions USD. Compared to the peer group median of 6.66 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Zhangzhou Pientzehuang Pharmaceutical rank on GHG emissions intensity within its industry?

In 2023, Zhangzhou Pientzehuang Pharmaceutical ranked 7 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Zhangzhou Pientzehuang Pharmaceutical is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Zhangzhou Pientzehuang Pharmaceutical's GHG Emissions Dataset?
Sign Up